Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of Human dermal fibroblasts for the treatment of lower back pain

Next Previous
Trial Profile

A clinical trial of Human dermal fibroblasts for the treatment of lower back pain

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 19 Dec 2018 New trial record
  • 28 Nov 2018 According to the SpinalCyte media release, the U.S. FDA has approved the Investigational New Drug application for fibroblast cell therapy for the treatment of lower back pain in the U.S. The trial is to be initiated after the first production run is tested for quality and safety to meet the FDA stated criteria.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top